Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,221 to 1,240 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8+ T cells. | Sci Rep | 2021 | 33911146 | PubTator, text mining | PubMed |
| Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade. | Mol Cell | 2021 | 33909988 | PubTator, text mining | PubMed |
| Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review. | Transl Lung Cancer Res | 2021 | 33889529 | PubTator, text mining | PubMed |
| VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma. | Oncoimmunology | 2021 | 33889438 | PubTator, text mining | PubMed |
| Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas. | Hum Pathol | 2021 | 33887301 | PubTator, text mining | PubMed |
| Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue. | Sci Rep | 2021 | 33875760 | PubTator, text mining | PubMed |
| B7 Family Members in Lymphoma: Promising Novel Targets for Tumor Immunotherapy? | Front Oncol | 2021 | 33869045 | PubTator, text mining | PubMed |
| miR-140 inhibits osteosarcoma progression by impairing USP22-mediated LSD1 stabilization and promoting p21 expression. | Mol Ther Nucleic Acids | 2021 | 33868787 | PubTator, text mining | PubMed |
| Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape. | Front Immunol | 2021 | 33868274 | PubTator, text mining | PubMed |
| Abnormal expression of the costimulatory molecule B7-H4 in placental chorionic villous and decidual basalis tissues of patients with preeclampsia and HELLP syndrome. | Am J Reprod Immunol | 2021 | 33864713 | PubTator, text mining | PubMed |
| Role of serotonin receptor signaling in cancer cells and anti-tumor immunity. | Theranostics | 2021 | 33859748 | PubTator, text mining | PubMed |
| A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma. | Cancer Biol Med | 2021 | 33856140 | PubTator, text mining | PubMed |
| COL1A1 is a prognostic biomarker and correlated with immune infiltrates in lung cancer. | PeerJ | 2021 | 33850663 | PubTator, text mining | PubMed |
| The Role of CD276 in Cancers. | Front Oncol | 2021 | 33842369 | PubTator, text mining | PubMed |
| Immunomodulatory function of the active ingredients in traditional Chinese prescriptions on early stage esophageal cancer with dysplasia. | Am J Transl Res | 2021 | 33841688 | PubTator, text mining | PubMed |
| Seven interferon gamma response genes serve as a prognostic risk signature that correlates with immune infiltration in lung adenocarcinoma. | Aging (Albany NY) | 2021 | 33839701 | PubTator, text mining | PubMed |
| Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC. | J Thorac Oncol | 2021 | 33839362 | PubTator, text mining | PubMed |
| Immune-Inhibitory Gene Expression is Positively Correlated with Overall Immune Activity and Predicts Increased Survival Probability of Cervical and Head and Neck Cancer Patients. | Front Mol Biosci | 2021 | 33834038 | PubTator, text mining | PubMed |
| Immune checkpoint molecules B7-H6 and PD-L1 co-pattern the tumor inflammatory microenvironment in human breast cancer. | Sci Rep | 2021 | 33824367 | PubTator, text mining | PubMed |
| Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies. | Front Immunol | 2021 | 33815418 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=62